查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008753

生物標記技術市場報告：按檢測類型、適應症、產品類型、技術、應用和地區分類（2026-2034 年）

Biomarker Technologies Market Report by Test Type, Indication, Product, Technology (Polymerase Chain Reaction, Next Generation Sequencing, Immunoassay, and Others), Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

全球生物標記技術市場在2025年達到500億美元。展望未來，IMARC Group預測，到2034年，該市場將達到1,294億美元，2026年至2034年的複合年成長率為10.80%。該市場正經歷穩定成長，其成長動力來自醫療保健、製藥和診斷領域應用範圍的擴大，以及人們對精準醫療和疾病檢測日益成長的興趣，以及對非侵入性診斷方法的需求不斷成長。

生物標記技術市場的發展趨勢：

精準醫療的需求日益成長

精準醫療需求的日益成長是生物標記技術市場的主要驅動力。精準醫療代表醫療保健領域的模式轉移，旨在根據患者獨特的基因、分子和臨床特徵提供個人化的治療策略。生物標記在這一轉變中發揮著至關重要的作用。生物標記是反映體內各種生物過程的可測量指標。在精準醫療的背景下，生物標記是識別特定疾病亞型、預測疾病進展和確定最有效治療方法的重要工具。透過分析生物標記，醫療專業人員可以為每位患者量身定做治療性介入，最佳化治療效果，同時最大限度地減少潛在的副作用。精準醫療最吸引人的方面之一是其革新癌症治療的潛力。生物標記技術使腫瘤學家能夠識別腫瘤內的基因突變和蛋白質標記物，從而選擇針對癌症潛在分子因素的標靶治療。這提高了治療成功率，減少了試驗錯療法的必要性，使患者避免無效治療和不必要的毒性，並最終促進了市場成長。

體學技術的進步

體學技術的進步是生物標記技術市場的另一個重要驅動力。體學涵蓋基因組學、蛋白質組學和代謝體學等多個科學領域，每個領域都在生物標記的發現和開發中發揮著至關重要的作用。基因組學研究個體的全部DNA序列，從而深入了解與疾病相關的基因變異和突變。 DNADNA測序技術的不斷進步使得基因組分析更加快速高效，並降低了成本，進而鑑定出眾多與各種疾病相關的遺傳生物標記。這些豐富的基因組數據拓展了個人化醫療和標靶治療開發的可能性。蛋白質體學專注於研究生物系統中的蛋白質。質譜和其他創新的蛋白質組學技術使研究人員能夠識別與疾病和治療反應相關的特定蛋白質生物標記。這些生物標記在改善疾病診斷、監測和藥物研發方面具有巨大的潛力。代謝體學分析生物檢體中的小分子和代謝物，以闡明代謝途徑及其異常。因此，體學技術的進步不斷豐富生物標記工具箱，促進新生物標記的發現，加深我們對疾病的理解，並推動診斷和藥物發現的創新。

慢性疾病負擔日益加重

慢性疾病負擔日益加重是生物標記技術市場成長的關鍵促進因素。心血管疾病、糖尿病、癌症和呼吸系統疾病等慢性疾病構成日益嚴峻的全球健康挑戰。人口老化、生活方式改變和環境因素等都導致了這些疾病盛行率的上升。生物標記技術已成為對抗慢性疾病的重要工具。它們具有早期精準檢測的潛力，這對於有效疾病管理和改善患者預後至關重要。生物標記能夠識別體內細微的變化，這些變化提示慢性疾病的發生或進展，甚至在臨床症狀出現之前即可發現。這種早期檢測使醫療專業人員能夠迅速介入，實施個人化治療方案，並更密切地監測疾病進展。隨著全球慢性疾病負擔的持續加重，對支持早期檢測、精準監測和個人化治療策略的生物標記技術的需求也日益成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球生物標記技術市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依測試類型分類

  • 固態切片檢查
  • 液態切片

第7章 市場區隔：依適應症分類

  • 癌症
  • 感染疾病
  • 自體免疫疾病
  • 心血管疾病
  • 其他

第8章 市場區隔：依產品分類

  • 消耗品
  • 偵測
  • 試劑
  • 裝置

第9章 市場區隔：依技術分類

  • 聚合酵素鏈鎖反應（PCR）
  • 次世代定序（NGS）
  • 免疫檢測
  • 其他

第10章 市場區隔：依應用領域分類

  • 藥物發現
  • 臨床診斷
  • 個人化醫療

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章：價格分析

第16章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • LI-COR Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112026A4341

The global biomarker technologies market size reached USD 50.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 129.4 Billion by 2034, exhibiting a growth rate (CAGR) of 10.80% during 2026-2034. The market is experiencing steady growth, driven by increasing applications in healthcare, pharmaceuticals, and diagnostics, coupled with a heightening focus on precision medicine and disease detection and the rising demand for non-invasive diagnostic methods.

BIOMARKER TECHNOLOGIES MARKET ANALYSIS:

  • Market Growth and Size: The market is currently witnessing stable growth, fueled by its increasing applications in healthcare, pharmaceuticals, and diagnostics. Additionally, the integration of biomarker technologies into research and development (R&D) processes further fuels this stable growth, enhancing their pivotal role in advancing healthcare, pharmaceuticals, and diagnostics.
  • Rising Demand for Non-Invasive Diagnostic Methods: The market witnesses an increasing demand for non-invasive diagnostic methods, driven by their patient-friendly nature, accuracy, and effectiveness in detecting diseases without the need for invasive procedures.
  • Industry Applications: The market is experiencing high demand from diverse industries, including healthcare, pharmaceuticals, and diagnostics, highlighting their versatility and widespread adoption.
  • Geographical Trends: North America leads the biomarker technologies market due to its robust infrastructure, significant investments in research and development, and a strong focus on healthcare innovation.
  • Competitive Landscape: The market is characterized by intense competition with key players focusing on innovation and expanding their market share, resulting in continuous advancements in biomarker technology.
  • Challenges and Opportunities: While regulatory hurdles present challenges, it also promises of personalized medicine and diagnostic breakthroughs that offers exciting opportunities for industry players.
  • Future Outlook : The future of the biomarker technologies market looks promising, especially in the realms of personalized medicine and enhanced disease detection.

BIOMARKER TECHNOLOGIES MARKET TRENDS:

Growing demand for precision medicine

The growing demand for precision medicine is a maior driving force in the biomarker technologies market. Precision medicine represents a paradigm shift in healthcare, aiming to provide personalized treatment strategies for patients based on their unique genetic, molecular, and clinical characteristics. Biomarkers play a pivotal role in this transformation. They are measurable indicators that reflect various biological processes within the body. In the context of precision medicine, they serve as crucial tools for identifying specific disease subtypes, predicting disease progression, and determining the most effective treatment approaches. By analyzing biomarkers, healthcare professionals can tailor interventions to individual patients, optimizing therapeutic outcomes while minimizing potential side effects. One of the most compelling aspects of precision medicine is its potential to revolutionize cancer care. Biomarker technologies allow oncologists to identify genetic mutations and protein markers in tumors, enabling the selection of targeted therapies that specifically address the underlying molecular drivers of cancer. This increases the chances of successful treatment and reduces the need for trial-and-error approaches, sparing patients from ineffective therapies and unnecessary toxicity, thereby fueling market growth.

Advancements in omics technologies

Advancements in omics technologies represent another significant driver in the biomarker technologies market. Omics encompasses various scientific disciplines, including genomics, proteomics, and metabolomics, each of which plays a crucial role in biomarker discovery and development. Genomics involves the study of an individual's complete set of DNA, providing insights into genetic variations and mutations associated with diseases. Ongoing advancements in DNA sequencing technologies have made it faster and more cost-effective to analyze the genome, leading to the identification of numerous genetic biomarkers linked to various conditions. This wealth of genomic data expands the potential for personalized medicine and the development of targeted therapies. Proteomics focuses on the study of proteins within biological systems. Mass spectrometry and other innovative proteomic techniques enable researchers to identify specific protein biomarkers associated with diseases or treatment responses. These biomarkers hold immense promise for improving disease diagnosis, monitoring, and drug development. Metabolomics examines the small molecules and metabolites in biological samples, shedding light on metabolic pathways and dysregulations. As a result, advancements in omics technologies continue to enrich the biomarker toolbox, facilitating the discovery of new biomarkers, enhancing our understanding of diseases, and driving innovation in diagnostics and drug development.

Increasing burden of chronic diseases

The escalating burden of chronic diseases is a significant factor propelling the growth of the biomarker technologies market. Chronic diseases, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, are a growing global health challenge. Factors like aging populations, lifestyle changes, and environmental factors contribute to the increasing prevalence of these conditions. Biomarker technologies have emerged as critical tools in the battle against chronic diseases. They offer the potential for early and accurate detection, which is crucial for effective disease management and improved patient outcomes. Biomarkers can identify subtle changes in the body that may indicate the onset or progression of a chronic disease, often before clinical symptoms manifest. This early detection empowers healthcare professionals to intervene promptly, implement personalized treatment plans, and monitor disease progression more closely. As the burden of chronic diseases continues to rise globally, there has been a heightened demand for biomarker technologies that support early detection, precise monitoring, and personalized treatment strategies.

BIOMARKER TECHNOLOGIES INDUSTRY SEGMENTATION:

Breakup by Test Type:

  • Solid Biopsy
  • Liquid Biopsy

Liquid biopsy accounts for the majority of the market share

Liquid biopsy has emerged as a transformative force in the biomarker technologies market. This non-invasive method involves analyzing biomarkers present in bodily fluids, such as blood or urine, to detect diseases, particularly cancer. Liquid biopsies offer numerous advantages, including early disease detection, real-time monitoring, and the ability to track treatment response. They reduce the need for invasive procedures and provide valuable information on tumor heterogeneity. As the demand for less invasive and more accessible diagnostic methods increases, liquid biopsies are driving the market further by expanding applications beyond traditional tissue-based biopsies and revolutionizing the field of diagnostics. Their potential to improve patient care and outcomes makes them a key market driver.

Solid biopsy methods involve the extraction of tissue samples from tumors or other abnormal growths for analysis. Solid biopsies provide essential biomarker data that guide treatment decisions, especially in cancer care. They also enable the identification of specific genetic, protein, or molecular markers, aiding in the selection of targeted therapies and predicting treatment responses. As precision medicine gains prominence, solid biopsy-derived biomarkers become indispensable, contributing to the market growth. Advancements in solid biopsy techniques, such as minimally invasive procedures, improve patient comfort and further fuel their adoption rate.

Breakup by Indication:

  • Cancer
  • Infectious Diseases
  • Autoimmune Disorders
  • Cardiovascular Disorders
  • Others

Cancer holds the largest share in the industry

Biomarker technologies are instrumental in the fight against cancer, providing essential tools for early detection, precise diagnosis, and tailored treatment strategies. They enable the identification of specific genetic and molecular markers, improving patient outcomes and driving substantial market growth in the oncology sector. They also play a crucial role in infectious disease management by facilitating rapid and accurate pathogen detection, monitoring treatment responses, and aiding in epidemiological studies, contributing significantly to the market's expansion, particularly in the context of global health crises.

Biomarker technologies are pivotal in diagnosing and monitoring autoimmune disorders, offering insights into disease progression and treatment efficacy, thus driving their adoption and furthering research in autoimmune disease management.

Biomarkers are indispensable in assessing cardiovascular health and risk factors. Their use in early diagnosis, monitoring, and personalized treatment plans fuels the demand for biomarker technologies, leading to advancements in cardiovascular care and fostering market growth.

Breakup by Product:

  • Consumables
  • Assay
  • Reagent
  • Instruments

Consumables represent the leading market segment

Consumables, including sample collection kits and containers, are vital components of biomarker technology workflows. They are essential for collecting and preserving biological samples, making them indispensable for research, diagnostics, and drug development. The steady demand for these consumables ensures a consistent revenue stream in the biomarker technologies market.

Assays are at the heart of biomarker analysis. They encompass a wide range of techniques, such as ELISA and PCR, used to detect and quantify specific biomarkers. The development of innovative assay methods and kits further catalyzed market growth as they enable more precise and efficient biomarker detection.

Reagents are essential chemical compounds used in various stages of biomarker analysis. They play a critical role in sample preparation, labeling, and detection. The continuous need for high-quality reagents, especially for emerging biomarkers, fuels market demand, making reagents a lucrative segment.

Biomarker detection instruments, such as mass spectrometers and PCR machines, are the technological backbone of biomarker analysis. Advances in instrument capabilities, including sensitivity and throughput, significantly impact market growth. As research and diagnostic needs evolve, there has been a rise in the demand for cutting-edge biomarker detection instruments.

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)
  • Next Generation Sequencing (NGS)
  • Immunoassay
  • Others

Immunoassay accounts for the majority of market share

Immunoassays are key for detecting protein biomarkers. They offer specificity, making them crucial in clinical diagnostics and research. Constant innovation in immunoassay platforms and reagents continues to propel the biomarker technologies market forward, enhancing biomarker detection sensitivity and precision.

Polymerase Chain Reaction (PCR) technology revolutionized biomarker analysis by enabling the amplification of DNA sequences. It plays a pivotal role in identifying genetic biomarkers, offering high specificity and sensitivity. Its versatility in applications, from disease diagnostics to gene expression analysis, ensures its enduring importance in the biomarker technologies market.

Next Generation Sequencing (NGS) technology enables comprehensive genomic and transcriptomic analysis. It contributes to biomarker discovery by identifying genetic variations associated with diseases. Its ability to process large datasets rapidly has accelerated research, making NGS a major driving force in biomarker-related advancements.

Breakup by Application:

  • Drug Discovery
  • Clinical Diagnostics
  • Personalized Medicine

Drug discovery represents the leading market segment

Biomarker technologies are indispensable in drug discovery, aiding in target identification, validation, and efficacy assessment. They streamline the drug development process by identifying potential therapeutic targets and predicting drug responses, reducing costs and accelerating time to market.

In clinical diagnostics, biomarkers play a pivotal role in disease diagnosis, prognosis, and treatment monitoring. Their use enhances healthcare by enabling early disease detection and personalized treatment plans, spurring the adoption of biomarker technologies in clinical settings, ultimately improving patient outcomes.

Biomarker technologies are the cornerstone of personalized medicine, allowing healthcare providers to tailor treatments based on individual patient profiles. This approach improves treatment efficacy, reduces adverse effects, and fosters patient-centric healthcare, thus fueling the growth of biomarker technologies in personalized medicine applications, revolutionizing healthcare delivery.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest biomarker technologies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region boasts a robust infrastructure, significant R&D investments, and a focus on healthcare innovation. The region's commitment to cutting-edge research and clinical applications positions it as a key driver of biomarker technology advancement.

Asia Pacific is also an expanding market for biomarker technologies owing to increasing healthcare investments, growing research capabilities, and a rising burden of chronic diseases. The region's emphasis on precision medicine and personalized healthcare drives demand for biomarker-based diagnostics and treatment strategies.

Europe's biomarker technologies market benefits from strong collaborations between academia and industry. It thrives on the continent's commitment to healthcare innovation, making it a prominent player in biomarker research and application development.

Biomarker technologies are rapidly gaining traction in the Middle East and Africa, supported by a growing demand for improved healthcare solutions. The region's increasing healthcare expenditure and heightened focus on disease prevention contribute to the adoption of biomarker-based diagnostics.

Latin America exhibits a growing biomarker technologies market, fueled by the rising prevalence of chronic diseases and a growing awareness of personalized medicine. The region's expanding healthcare infrastructure and research initiatives are driving the demand for biomarker-based solutions, making it a notable contributor to market growth.

LEADING KEY PLAYERS IN THE BIOMARKER TECHNOLOGIES INDUSTRY:

Various key players in the market are actively engaging innovation and strategic partnerships to maintain their competitive edge. They are also investing in research and development to enhance the sensitivity and specificity of biomarker detection methods. Additionally, these companies are expanding their product portfolios to cover a broader range of biomarkers and applications, catering to the growing demand for personalized medicine. Collaborations with academic institutions and pharmaceutical companies are common, fostering the discovery and validation of novel biomarkers. Moreover, these market leaders are focused on complying with regulatory standards to ensure the safety and effectiveness of their biomarker-based products, ultimately shaping the future of diagnostics and treatment in healthcare.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • LI-COR Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Key Questions Answered in This Report:

  • How has the global biomarker technologies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biomarker technologies market?
  • What is the impact of each driver, restraint, and opportunity on the global biomarker technologies market?
  • What are the key regional markets?
  • Which countries represent the most attractive biomarker technologies market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the biomarker technologies market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the biomarker technologies market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biomarker technologies market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biomarker technologies market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biomarker technologies market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biomarker technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomarker Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Solid Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liquid Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autoimmune Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Assay
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Reagent
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Instruments
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Polymerase Chain Reaction (PCR)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Next Generation Sequencing (NGS)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immunoassay
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Drug Discovery
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Diagnostics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Personalized Medicine
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Danaher Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 F. Hoffmann-La Roche AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Illumina Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 LI-COR Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Merck KGaA
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 QIAGEN N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Waters Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2025
  • Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2025
  • Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2025
  • Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2025
  • Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: China: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: India: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: France: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2025
  • Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
  • Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
  • Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Biomarker Technologies Market: Competitive Structure
  • Table 9: Global: Biomarker Technologies Market: Key Players